Quick Answer
Addex Therapeutics Ltd. reported Total Assets of $10.68 million for fiscal year 2024.
Addex Therapeutics Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $10.68M | +130.0% |
| 2023 | $4.64M | -44.0% |
| 2022 | $8.28M | -63.3% |
| 2021 | $22.54M | +11.7% |
| 2020 | $20.18M | -38.9% |
| 2019 | $33.03M | -21.8% |
| 2018 | $42.21M | — |
- Addex Therapeutics Ltd. showed an increase of +130.0% in Total Assets compared to the prior fiscal year.
- Over the 2018–2024 period, Addex Therapeutics Ltd.’s total assets has declined by 74.7% (from $42.21 million to $10.68 million).
- The most recent figure is from Addex Therapeutics Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: